Manufacturer record

Synokem Pharmaceuticals Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

15 batches manufactured by Synokem Pharmaceuticals Ltd (Uttarakhand) were declared Not of Standard Quality between February 2019 and November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

15 records linked to Synokem Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
15Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2019 to Nov 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

15
NSQ batches since 2019
13
Products affected
Dissolution
Most common failure
Nov 2024
Latest alert

Flagged batches per year

2019 · 42020 · 22021 · 42022 · 22023 · 22024 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Itraconazole Capsules BP 200 mg (Itrotus- 200) 24S2GCA2 82Mfg 2024-04 · Exp 2026-03 DissolutionDissolution RDTL GuwahatiCDSCO lab Nov 2024
Misoprostol Tablets I.P. 200 mcg 22S1GTA 026Mfg 2022-01 · Exp 2023-12 AssayAssay CDL KolkataCDSCO lab Aug 2023
Gabapentin Tablets I.P. 22S1GTB467Mfg 2022-11 · Exp 2024-10 Related SubstancesRelated substances CDTL KolkataCDSCO lab Mar 2023
Rosuvastatin Calcium Tablets IP 10 mg 21S1GTA035Mfg 2021-01 · Exp 2022-12 DissolutionDissolution RDTL GuwahatiState lab Sep 2022
Rosuvastatin Calcium Tablets IP 10mg 21S1GTA035Mfg 2021-01 · Exp 2022-12 DissolutionDissolution RDTL GuwahatiState lab May 2022
Olmesartan Medoxomil Tablets IP Olmesartan Medoxomil I.P. 40mg 20S1GTA060Mfg 2020-06 · Exp 2022-05 DissolutionDissolution RDTL GuwahatiCDSCO lab Sep 2021
Progesterone Sustained- Release Tablets (FULGEST SR 200 TABLETS) GFSM008Mfg 2019-06 · Exp 2021-05 DissolutionDissolution RDTL ChandigarhCDSCO lab Apr 2021
L-CETAM 500 (Levetiracetam Tablets I.P. 500 mg) 20S1GTA508Mfg 2020-11 · Exp 2022-10 DissolutionDissolution CDL KolkataCDSCO lab Apr 2021
CORSAVE-10 (Rosuvastatin Calcium Tablets I.P. 10 mg) 19SGLT011Mfg 2019-12 · Exp 2021-11 Related SubstancesRelated substances CDL KolkataCDSCO lab Mar 2021
Rosloy ASP 10/75 (Rosuvastatin & Aspirin Capsules) 19ISGC040Mfg 2019-09 · Exp 2021-02 Assay of RosuvastatinAssay CDTL MumbaiCDSCO lab Nov 2020
Paracetamol Tablets IP (SYNPAR TABLETS) 19SGJT005Mfg 2019-10 · Exp 2021-09 DissolutionDissolution RDTL ChandigarhCDSCO lab Mar 2020
Atorvastatin Calcium Tablets IP 40mg 19SGBT032Mfg 2019-02 · Exp 2021-01 DissolutionDissolution CDTL MumbaiCDSCO lab Oct 2019
Misoprostol Tablets I.P. 200 mcg MST 18SGET035Mfg 2018-05 · Exp 2020-04 AssayAssay CDL KolkataCDSCO lab May 2019
Misoprostol Tablets I.P. 200 mcg, 18SGCT012Mfg 2018-03 · Exp 2020-02 AssayAssay CDSCO, East Zone, KolkataState lab Feb 2019
Azithromycin Oral Suspension IP (AZM-200 SUSPENSION) 17SGDL002Mfg 2017-04 · Exp 2019-03 Related substances and the Assay of Azithromycin calculated as Anhydrous AzithromycinAssay RDTL ChandigarhState lab Feb 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.